IDXX

IDEXX Laboratories
D

IDXX

Arincen86/100B

IDEXX Laboratories operating income 1991–2026

IDEXX Laboratories's operating income in Q3 FY2026, the three months to 30 September 2026, was 402.35M USD, up 13.4% on the same quarter a year before. IDEXX Laboratories's operating income over the last twelve months was 1.51B USD, up 15.3% on the twelve months before. In fiscal year 2025 it was 1.36B USD, up 20.5% on the year before.

Last updated 7 Nov 2026 · Next report 1 Feb 2027

Operating income

Operating income · +16.3% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM30 Sept 20261.51B+15.31%32.30%2.92B62.72%1.67B
FY202531 Dec 20251.36B+20.53%31.60%2.66B61.80%1.51B
FY202431 Dec 20241.13B+2.84%28.95%2.38B61.04%1.28B
FY202331 Dec 20231.10B+22.07%29.97%2.19B59.82%1.22B
FY202231 Dec 2022898.77M-3.57%26.69%2.00B59.52%1.01B
FY202131 Dec 2021932.03M+34.20%28.99%1.89B58.76%1.04B
FY202031 Dec 2020694.52M+25.63%25.66%1.57B58.04%793.81M
FY201931 Dec 2019552.85M+12.52%22.97%1.37B56.73%643.68M
FY201831 Dec 2018491.34M+18.96%22.20%1.24B56.10%575.66M
FY201731 Dec 2017413.03M+17.93%20.98%1.10B55.73%501.42M
FY201631 Dec 2016350.24M+16.78%19.73%975.44M54.94%431.69M
FY201531 Dec 2015299.91M+15.24%18.72%890.27M55.58%370.29M
FY201431 Dec 2014260.26M-2.44%17.52%816.12M54.93%319.81M
FY201331 Dec 2013266.76M+1.60%19.37%756.12M54.91%322.34M
FY201231 Dec 2012262.56M+11.15%20.30%699.15M54.06%316.18M
FY201131 Dec 2011236.23M+15.86%19.38%646.51M53.05%284.75M
FY201031 Dec 2010203.88M+15.86%18.48%578.62M52.44%250.50M
FY200931 Dec 2009175.97M+2.04%17.06%526.28M51.01%226.23M
FY200831 Dec 2008172.46M+26.64%16.84%529.77M51.73%223.60M
FY200731 Dec 2007136.18M+6.45%14.76%463.52M50.24%177.28M
FY200631 Dec 2006127.93M+10.93%17.31%379.53M51.35%157.75M
FY200531 Dec 2005115.33M+6.75%18.07%322.90M50.60%139.70M
FY200431 Dec 2004108.04M+34.39%19.67%279.02M50.81%126.46M
FY200331 Dec 200380.39M+22.14%16.89%230.30M48.38%80.39M
FY200231 Dec 200265.82M+16.38%15.95%192.73M46.70%65.82M
FY200131 Dec 200156.55M+6.20%14.65%183.33M47.49%78.78M
FY200031 Dec 200053.25M+13.78%14.49%196.66M53.52%72.73M
FY199931 Dec 199946.80M+60.82%13.14%191.30M53.71%64.00M
FY199831 Dec 199829.10M—9.10%177.70M55.55%45.10M
FY199731 Dec 1997-4.40M-109.36%-1.67%143.20M54.45%10.00M
FY199631 Dec 199647.00M+42.86%17.56%164.80M61.56%57.40M
FY199531 Dec 199532.90M+44.30%17.44%113.40M60.13%38.60M
FY199431 Dec 199422.80M+64.03%18.04%77.70M61.47%27.30M
FY199331 Dec 199313.90M+172.55%14.93%58.90M63.27%17.70M
FY199231 Dec 19925.10M+96.15%8.84%36.00M62.39%8.60M
FY199131 Dec 19912.60M—8.52%18.70M61.31%3.60M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about IDEXX Laboratories's operating income

Source: Financial Modeling Prep